Moderna

Moderna MRNA Stock

$199.33   1.290721%
Add to favorites
Market Cap
$80.65B
LOW - HIGH [24H]
$189.98 - $205.22
VOLUME [24H]
$8.18M
P/E Ratio
0
Earnings per share
-$7.04
ISIN
US60770K1079
Price   Prediction

Moderna Price Chart

Sorry, that's all we've gotfor now...

Moderna (MRNA) stock price today is 199.33 USD on Tech Market Large (+1.29% on the day). Updated .

Moderna MRNA Financial and Trading Overview

Moderna stock price 199.33 USD
Previous Close 196.79 USD
Open 195.7 USD
Bid 181.45 USD x 100
Ask 202.78 USD x 100
Day's Range 189.98 - 205.22 USD
52 Week Range 22.28 - 280.8 USD
Volume 8.1M USD
Avg. Volume 19.16M USD
Market Cap 80.65B USD
Beta (5Y Monthly) 1.166
PE Ratio (TTM) N/A
EPS (TTM) -7.04 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 164.53 USD

MRNA Valuation Measures

Enterprise Value 78.68B USD
Trailing P/E N/A
Forward P/E -47.58722
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 31.941822
Price/Book (mrq) 11.778645
Enterprise Value/Revenue 31.162
Enterprise Value/EBITDA -44.13

Trading Information

Moderna Stock Price History

Beta (5Y Monthly) 1.166
52-Week Change 780.09%
S&P500 52-Week Change 12.00%
52 Week High 280.8 USD
52 Week Low 22.28 USD
50-Day Moving Average 205.61 USD
200-Day Moving Average 98.86 USD

MRNA Share Statistics

Avg. Volume (3 month) 19.16M USD
Avg. Daily Volume (10-Days) 9.68M USD
Shares Outstanding 404.62M
Float 377.36M
Short Ratio 1.75
% Held by Insiders 7.25%
% Held by Institutions 77.79%
Shares Short 33.19M
Short % of Float 9.99%
Short % of Shares Outstanding 8.19%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -110.45%
Operating Margin (ttm) -80.79%
Gross Margin -42.020%
EBITDA Margin -70.61%

Management Effectiveness

Return on Assets (ttm) -9.95%
Return on Equity (ttm) -34.50%

Income Statement

Revenue (ttm) 2.52B USD
Revenue Per Share (ttm) 6.37 USD
Quarterly Revenue Growth (yoy) 29.19%
Gross Profit (ttm) -1061000000 USD
EBITDA -1783000064 USD
Net Income Avi to Common (ttm) -2788999936 USD
Diluted EPS (ttm) -7.04
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 5.17B USD
Total Cash Per Share (mrq) 12.78 USD
Total Debt (mrq) 4.23B USD
Total Debt/Equity (mrq) 61.86 USD
Current Ratio (mrq) 3.621
Book Value Per Share (mrq) 16.923

Cash Flow Statement

Operating Cash Flow (ttm) -1784999936 USD
Levered Free Cash Flow (ttm) -584499968 USD

Profile of Moderna

Country United States
State MA
City Cambridge
Address 325 Binney Street
ZIP 02142
Phone 617 714 6500
Website https://www.modernatx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 4700

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Q&A For Moderna Stock

What is a current MRNA stock price?

Moderna MRNA stock price today per share is 199.33 USD.

How to purchase Moderna stock?

You can buy MRNA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Moderna?

The stock symbol or ticker of Moderna is MRNA.

Which industry does the Moderna company belong to?

The Moderna industry is Biotechnology.

How many shares does Moderna have in circulation?

The max supply of Moderna shares is 404.62M.

What is Moderna Price to Earnings Ratio (PE Ratio)?

Moderna PE Ratio is now.

What was Moderna earnings per share over the trailing 12 months (TTM)?

Moderna EPS is -7.04 USD over the trailing 12 months.

Which sector does the Moderna company belong to?

The Moderna sector is Healthcare.

Moderna MRNA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 23879.2 USD —
-2.25
8.33B USD — 23870.7 USD — 24939.62 USD — — 8.33B USD —
us S&P 500 INDEX SPX US 7175.83 USD —
-2.02
3.38B USD — 7173.63 USD — 7415.64 USD — — 3.38B USD —
us S&P 500 (Yahoo.com) GSPC US 7175.83 USD —
-2.02
3.34B USD — 7173.63 USD — 7415.64 USD — — 3.34B USD —
us US100 NDX US 26517.05 USD —
-2.21
1.71B USD — 26481.82 USD — 27749.35 USD — — 1.71B USD —
us US Tech-100 ESG JPY Index NDXESG07 US 2855.06 JPY 17.6 USD
-1.9
— — 2848.35 JPY 17.56 USD 2996.21 JPY 18.48 USD — — —
us US Tech-100 PM Settlement Value XQC US 16331.98 USD —
+1.13
— — 16331.98 USD — 16331.98 USD — — — —
us US Tech-100 Notional Net Total R XNDXNNR US 30930.45 USD —
-2.2
— — 30889.15 USD — 32367.68 USD — — — —
us US Tech Biotechnology NBI US 6901.37 USD —
-1.01
— — 6893.3 USD — 7033.67 USD — — — —
us US Tech Health Care IXHC US 1306.01 USD —
-1.39
— — 1303.72 USD — 1333.62 USD — — — —
us US Tech-100 After Hours Indicato QIV US 26391.22 USD —
-2.67
— — 26370.63 USD — 26516.82 USD — — — —
us US Tech US BuyBack Achievers Sel DRBS US 2340.09 USD —
+0.42
— — 2336.31 USD — 2349.71 USD — — — —
us US Tech US Smart Pharmaceuticals NQSSPH US 2232.16 USD —
-2.21
— — 2228.96 USD — 2284.66 USD — — — —
us US Tech US CapEx Achievers Index CAPEXA US 3729.85 USD —
-1.97
— — 3729.53 USD — 3827.68 USD — — — —
us Stlmt ID US Tech 100 XQO US 16266.86 USD —
-0.45
— — 15738.2 USD — 16639.8 USD — — — —
us US Tech Global Select Market Com NQGS US 11763.07 USD —
-2.26
— — 11758.76 USD — 12288.24 USD — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
us US Tech-100 ESG Net Notional Tot NDXESG24 US 2186.6 EUR 2524.07 USD
-2.35
— — 2184.63 EUR 2521.79 USD 2291.12 EUR 2644.72 USD — — —
us US Tech-100 Equal Weighted NDXE US 9287.67 USD —
-1.88
— — 9282.08 USD — 9618.29 USD — — — —
us US Tech-100 Notional Net Return XNDXNNREUR US 5059.01 EUR 5839.79 USD
-2.34
— — 5054.23 EUR 5834.27 USD 5289.85 EUR 6106.25 USD — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.15T
Total marketcap
$75.62B
Total volume
BTC 57.95%   •   ETH 9.95%
Dominance
Select currency